TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TOwards Prepared Mums (TOP-mums), for a Healthy Start: A Lifestyle Intervention to Reduce Overweight and Smoking in Women With a Pregnancy Wish to Prevent Perinatal Morbidity
Brief Summary: This study evaluates the effect of a lifestyle intervention for women with a pregnancy wish who have a high risk on perinatal morbidity because of overweight or obesity. Half of the patients will receive the lifestyle intervention while the other half will receive usual care. It is hypothesized that an effective lifestyle intervention directed towards healthy living, including reduction of overweight or obesity and, if applicable, smoking reduction, health problems in mothers and their offspring can be prevented.


Options:
A: Arm Label: Control (Spa Certificate); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control | Arm Label: Mind/Body Program; Type: EXPERIMENTAL; Interventions: Behavioral: Mind/Body Program | Intervention Type: BEHAVIORAL; Name: Mind/Body Program; Assigned to Arm(s): Mind/Body Program | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control (Spa Certificate)
B: Arm Label: Positive adjustment coping intervention; Type: EXPERIMENTAL; Interventions: Other: Positive adjustment coping intervention | Arm Label: Brainteaser; Type: OTHER; Interventions: Other: Brainteaser | Intervention Type: OTHER; Name: Positive adjustment coping intervention; Assigned to Arm(s): Positive adjustment coping intervention | Intervention Type: OTHER; Name: Brainteaser; Assigned to Arm(s): Brainteaser
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PEPCI group; Type: EXPERIMENTAL; Interventions: Procedure: PEPCI | Intervention Type: PROCEDURE; Name: PEPCI; Assigned to Arm(s): PEPCI group
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fit For Function: A Community Wellness Program for Persons With Stroke
Brief Summary: Building on an earlier pilot study, this randomized controlled trial will compare the effectiveness of a 12 week community YMCA-based wellness program specifically designed for people with stroke (Fit for Function) to a standard YMCA membership.


Options:
A: Arm Label: Fit For Function Program; Type: EXPERIMENTAL; Interventions: Other: Fit For Function Program | Arm Label: Standard YMCA membership; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard YMCA membership | Intervention Type: OTHER; Name: Fit For Function Program; Assigned to Arm(s): Fit For Function Program | Intervention Type: OTHER; Name: Standard YMCA membership; Assigned to Arm(s): Standard YMCA membership
B: Arm Label: 1- tDCS 2--FES; Type: EXPERIMENTAL; Interventions: Device: Transcranial direct current stimulation (tDCS), Device: Functional electrical stimulation (FES), Device: Sham stimulation | Intervention Type: DEVICE; Name: Transcranial direct current stimulation (tDCS); Assigned to Arm(s): 1- tDCS 2--FES | Intervention Type: DEVICE; Name: Functional electrical stimulation (FES); Assigned to Arm(s): 1- tDCS 2--FES | Intervention Type: DEVICE; Name: Sham stimulation; Assigned to Arm(s): 1- tDCS 2--FES
C: Arm Label: Real stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany) | Arm Label: Sham stimulation; Type: SHAM_COMPARATOR; Interventions: Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany) | Intervention Type: DEVICE; Name: tdcs (ELDITH, Neuroconn, Ilmenau, Germany); Assigned to Arm(s): Real stimulation, Sham stimulation
D: Arm Label: real tDCS; Type: EXPERIMENTAL; Interventions: Device: tDCS | Arm Label: sham tDCS; Type: SHAM_COMPARATOR; Interventions: Device: tDCS | Arm Label: no stimulation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: tDCS; Assigned to Arm(s): real tDCS, sham tDCS

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fit For Function: A Community Wellness Program for Persons With Stroke
Brief Summary: Building on an earlier pilot study, this randomized controlled trial will compare the effectiveness of a 12 week community YMCA-based wellness program specifically designed for people with stroke (Fit for Function) to a standard YMCA membership.


Options:
A: Arm Label: Fit For Function Program; Type: EXPERIMENTAL; Interventions: Other: Fit For Function Program | Arm Label: Standard YMCA membership; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard YMCA membership | Intervention Type: OTHER; Name: Fit For Function Program; Assigned to Arm(s): Fit For Function Program | Intervention Type: OTHER; Name: Standard YMCA membership; Assigned to Arm(s): Standard YMCA membership
B: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Other: Ballistic Strength Training | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Physiotherapy | Intervention Type: OTHER; Name: Ballistic Strength Training; Assigned to Arm(s): Experimental | Intervention Type: OTHER; Name: Usual Care Physiotherapy; Assigned to Arm(s): Control
C: Arm Label: Long term follow up program; Type: EXPERIMENTAL; Interventions: Behavioral: Long term follow up by a coordinating physiotherapist | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Intervention Type: BEHAVIORAL; Name: Long term follow up by a coordinating physiotherapist; Assigned to Arm(s): Long term follow up program | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard care
D: Arm Label: With isokinetic strength training; Type: EXPERIMENTAL; Interventions: Other: isokinetic strength training | Arm Label: without isokinetic strength training; Type: PLACEBO_COMPARATOR; Interventions: Other: passive motion | Intervention Type: OTHER; Name: isokinetic strength training; Assigned to Arm(s): With isokinetic strength training | Intervention Type: OTHER; Name: passive motion; Assigned to Arm(s): without isokinetic strength training

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The aim of the present study was to determine the effects of fortified soy milk with L. planetarium A7 on a cytokine receptor, an adipokine and renal function biomarkers in type II diabetic patients with nephropathy.


Options:
A: Arm Label: Corn Starch; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Corn starch | Arm Label: Fiber; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Fiber | Intervention Type: DIETARY_SUPPLEMENT; Name: Fiber; Assigned to Arm(s): Fiber | Intervention Type: DIETARY_SUPPLEMENT; Name: Corn starch; Assigned to Arm(s): Corn Starch
B: Arm Label: probiotic soy milk; Type: EXPERIMENTAL; Interventions: Dietary Supplement: probiotic soy milk | Arm Label: soy milk; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: probiotic soy milk | Intervention Type: DIETARY_SUPPLEMENT; Name: probiotic soy milk; Assigned to Arm(s): probiotic soy milk, soy milk
C: Arm Label: Synbiotic Arm; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Synbiotics containing Lactobacillus acidophilus & Bifidobacterium longum 5x10^9 CFU and FOS 60 mg | Arm Label: Placebo Arm; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Synbiotics containing Lactobacillus acidophilus & Bifidobacterium longum 5x10^9 CFU and FOS 60 mg; Assigned to Arm(s): Synbiotic Arm | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo Arm
D: Arm Label: Fructooligosaccharide; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Fructooligosaccharide | Arm Label: Maltodextrin; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Maltodextrin | Intervention Type: DIETARY_SUPPLEMENT; Name: Fructooligosaccharide; Assigned to Arm(s): Fructooligosaccharide | Intervention Type: DIETARY_SUPPLEMENT; Name: Maltodextrin; Assigned to Arm(s): Maltodextrin

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures
Brief Summary: The present study has been planned to assess the level of serum neuron-specific enolase (NSE) in focal seizures and its changes after antiepileptic therapy.


Options:
A: Arm Label: Keppra XR 1000 mg/day; Type: EXPERIMENTAL; Interventions: Drug: Keppra XR | Arm Label: Keppra XR 2000 mg/day; Type: EXPERIMENTAL; Interventions: Drug: Keppra XR | Intervention Type: DRUG; Name: Keppra XR; Assigned to Arm(s): Keppra XR 1000 mg/day | Intervention Type: DRUG; Name: Keppra XR; Assigned to Arm(s): Keppra XR 2000 mg/day
B: Arm Label: Lacosamide; Type: EXPERIMENTAL; Interventions: Drug: Lacosamide | Arm Label: Carbamazepine-Controlled Release (CBZ-CR); Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbamazepine-Controlled Release | Intervention Type: DRUG; Name: Lacosamide; Assigned to Arm(s): Lacosamide | Intervention Type: DRUG; Name: Carbamazepine-Controlled Release; Assigned to Arm(s): Carbamazepine-Controlled Release (CBZ-CR)
C: Arm Label: Healthy control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Carbamazepine group; Type: EXPERIMENTAL; Interventions: Drug: Carbamazepine | Arm Label: Oxcarbazepine group; Type: EXPERIMENTAL; Interventions: Drug: Oxcarbazepine | Intervention Type: DRUG; Name: Carbamazepine; Assigned to Arm(s): Carbamazepine group | Intervention Type: DRUG; Name: Oxcarbazepine; Assigned to Arm(s): Oxcarbazepine group
D: Arm Label: lamotrigine 300; Type: EXPERIMENTAL; Interventions: Drug: lamotrigine, 300 mg/day | Arm Label: lamotrigine 250; Type: EXPERIMENTAL; Interventions: Drug: lamotrigine, 250 mg/day | Intervention Type: DRUG; Name: lamotrigine, 300 mg/day; Assigned to Arm(s): lamotrigine 300 | Intervention Type: DRUG; Name: lamotrigine, 250 mg/day; Assigned to Arm(s): lamotrigine 250

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Oxygenation by 100% Oxygen Via High Flow Nasal Cannula During Apnea in Adult Elective Surgical ENT Patients
Brief Summary: Oxygenation with high-flow nasal cannula with 100% oxygen has only been evaluated in a limited number of studies. Although data are convincing it is of importance to evaluate this new concept in our department before implementing it into clinical practice.

The general purpose of this project is to evaluate a new ventilation strategy during ENT-surgery based on oxygenation with high-flow nasal cannula with 100% oxygen with focus on gas exchange.


Options:
A: Arm Label: Pre-oxygenation with a standard anaesthetic face mask; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard anaesthetic face mask | Arm Label: Pre-oxygenation using Optiflow and THRIVE technique; Type: EXPERIMENTAL; Interventions: Device: Optiflow and THRIVE technique | Intervention Type: DEVICE; Name: Optiflow and THRIVE technique; Assigned to Arm(s): Pre-oxygenation using Optiflow and THRIVE technique | Intervention Type: DEVICE; Name: Standard anaesthetic face mask; Assigned to Arm(s): Pre-oxygenation with a standard anaesthetic face mask
B: Arm Label: Normoventilation; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Hyperventilation; Type: EXPERIMENTAL; Interventions: Procedure: Hyperventilation | Intervention Type: PROCEDURE; Name: Hyperventilation; Assigned to Arm(s): Hyperventilation
C: Arm Label: High flow oxygen delivery; Type: EXPERIMENTAL; Interventions: Device: High flow nasal cannula oxygen delivery | Arm Label: Low Flow oxygen delivery; Type: EXPERIMENTAL; Interventions: Device: Low flow nasal cannula oxygen delivery | Arm Label: Standard practice of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: High flow nasal cannula oxygen delivery; Assigned to Arm(s): High flow oxygen delivery | Intervention Type: DEVICE; Name: Low flow nasal cannula oxygen delivery; Assigned to Arm(s): Low Flow oxygen delivery
D: Arm Label: Nasal high-flow oxygen therapy; Type: EXPERIMENTAL; Interventions: Device: Optiflow (Fisher & Paykel Healthcare) | Arm Label: Venturi mask oxygen therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Venturi mask | Intervention Type: DEVICE; Name: Optiflow (Fisher & Paykel Healthcare); Assigned to Arm(s): Nasal high-flow oxygen therapy | Intervention Type: DEVICE; Name: Venturi mask; Assigned to Arm(s): Venturi mask oxygen therapy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Supplementation With Resistant Starch in the Profile of the Intestinal Tract and Cardiovascular Markers in Patients With Chronic Kidney Disease
Brief Summary: The objective of this study is to assess whether supplementation with resistant starch from the rice-flour coffee developed by EMBRAPA, as well as from an already industrialized product (Hi-Maize of Ingredion®) could modulate the intestinal microbiota of patients with CKD ( both patients under conservative treatment, such as dialysis treatment), as well as exerting a beneficial effect with respect to reducing levels of inflammatory markers of oxidative stress, uremic toxins and in addition, markers of cardiovascular disease.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Probiotic packet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotic packet | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic packet; Assigned to Arm(s): Probiotic packet | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Gum Arabic | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: C; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Gum Arabic | Arm Label: D; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Gum Arabic | Intervention Type: DIETARY_SUPPLEMENT; Name: Gum Arabic; Assigned to Arm(s): A, C, D | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): B
C: Arm Label: resistance starch for CKD; Type: EXPERIMENTAL; Interventions: Dietary Supplement: 'resistance starch for CKD | Arm Label: cross-over period; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: 'resistance starch for CKD; Assigned to Arm(s): resistance starch for CKD | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): cross-over period
D: Arm Label: Resistant Potato Starch; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Resistant Potato Starch, Corn Starch | Arm Label: Corn Starch; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Corn Starch, Resistant Potato Starch | Intervention Type: DIETARY_SUPPLEMENT; Name: Resistant Potato Starch, Corn Starch; Assigned to Arm(s): Resistant Potato Starch | Intervention Type: DIETARY_SUPPLEMENT; Name: Corn Starch, Resistant Potato Starch; Assigned to Arm(s): Corn Starch

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Additional Trunk Exercises on Gait Performance: a Randomised Controlled Trial
Brief Summary: The aim of SWEAT² study is to further explore the effects of additional customized trunk exercises on clinical and biomechanical gait performance. Despite of the evidence demonstrating the importance of trunk control after stroke, studies about the effects of trunk rehabilitation on gait performance are inconsistent. The findings of this study might lead to new scientific insights in the importance of the trunk during gait rehabilitation in people suffering from stroke submitted to a rehabilitation hospital.


Options:
A: Arm Label: Care Management+Community Health Worker; Type: EXPERIMENTAL; Interventions: Behavioral: Care Management+Community Health Worker | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Care Management+Community Health Worker; Assigned to Arm(s): Care Management+Community Health Worker | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Arm Label: Trunk training; Type: EXPERIMENTAL; Interventions: Other: Trunk training | Arm Label: Cognitive exercises; Type: SHAM_COMPARATOR; Interventions: Other: Cognitive exercises | Intervention Type: OTHER; Name: Trunk training; Assigned to Arm(s): Trunk training | Intervention Type: OTHER; Name: Cognitive exercises; Assigned to Arm(s): Cognitive exercises
C: Arm Label: Long term follow up program; Type: EXPERIMENTAL; Interventions: Behavioral: Long term follow up by a coordinating physiotherapist | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Intervention Type: BEHAVIORAL; Name: Long term follow up by a coordinating physiotherapist; Assigned to Arm(s): Long term follow up program | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard care
D: Arm Label: Exercise recommendation; Type: EXPERIMENTAL; Interventions: Other: Aerobic exercise | Arm Label: Aerobic exercise; Type: EXPERIMENTAL; Interventions: Other: Aerobic exercise | Intervention Type: OTHER; Name: Aerobic exercise; Assigned to Arm(s): Aerobic exercise, Exercise recommendation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Additional Trunk Exercises on Gait Performance: a Randomised Controlled Trial
Brief Summary: The aim of SWEAT² study is to further explore the effects of additional customized trunk exercises on clinical and biomechanical gait performance. Despite of the evidence demonstrating the importance of trunk control after stroke, studies about the effects of trunk rehabilitation on gait performance are inconsistent. The findings of this study might lead to new scientific insights in the importance of the trunk during gait rehabilitation in people suffering from stroke submitted to a rehabilitation hospital.


Options:
A: Arm Label: Trunk training; Type: EXPERIMENTAL; Interventions: Other: Trunk training | Arm Label: Cognitive exercises; Type: SHAM_COMPARATOR; Interventions: Other: Cognitive exercises | Intervention Type: OTHER; Name: Trunk training; Assigned to Arm(s): Trunk training | Intervention Type: OTHER; Name: Cognitive exercises; Assigned to Arm(s): Cognitive exercises
B: Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional physiotherapy | Arm Label: Target group; Type: EXPERIMENTAL; Interventions: Other: Conventional physiotherapy, Other: Techniques based on patients' functional level were added. | Intervention Type: OTHER; Name: Conventional physiotherapy; Assigned to Arm(s): Control group, Target group | Intervention Type: OTHER; Name: Techniques based on patients' functional level were added.; Assigned to Arm(s): Target group
C: Arm Label: Measurements and T-chair training; Type: EXPERIMENTAL; Interventions: Device: T-chair | Arm Label: Measurements; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: T-chair; Assigned to Arm(s): Measurements and T-chair training
D: Arm Label: Semi-immersive virtual reality; Type: EXPERIMENTAL; Interventions: Other: Semi-immersive virtual reality | Arm Label: Conventional Rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional Rehabilitation | Intervention Type: OTHER; Name: Semi-immersive virtual reality; Assigned to Arm(s): Semi-immersive virtual reality | Intervention Type: OTHER; Name: Conventional Rehabilitation; Assigned to Arm(s): Conventional Rehabilitation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Comparison of Once-daily Fixed combiNation vErsus freE-drug cOmbination of Three aNtihypertensive Agents in arteriaL hYpertension (the ONE&ONLY Trial)
Brief Summary: Randomized comparison of once-daily fixed combiNation versus free-drug combination of three antihypertensive agents in arterial hypertension


Options:
A: Arm Label: The Red Heart Pill 2b (Polypill) (A); Type: EXPERIMENTAL; Interventions: Drug: Red Heart Pill 2b (Polypill) | Arm Label: Standard Practice Group (B); Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Practice | Intervention Type: DRUG; Name: Red Heart Pill 2b (Polypill); Assigned to Arm(s): The Red Heart Pill 2b (Polypill) (A) | Intervention Type: OTHER; Name: Standard Practice; Assigned to Arm(s): Standard Practice Group (B)
B: Arm Label: Test and reference formulations; Type: EXPERIMENTAL; Interventions: Drug: Test formulation, Drug: Reference formulation | Intervention Type: DRUG; Name: Test formulation; Assigned to Arm(s): Test and reference formulations | Intervention Type: DRUG; Name: Reference formulation; Assigned to Arm(s): Test and reference formulations
C: Arm Label: FDC Fixed Dose Combination; Type: EXPERIMENTAL; Interventions: Drug: FDC | Arm Label: Conventional treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Separately drugs, simvastatin, aspirin and ramipril | Intervention Type: DRUG; Name: FDC; Assigned to Arm(s): FDC Fixed Dose Combination | Intervention Type: DRUG; Name: Separately drugs, simvastatin, aspirin and ramipril; Assigned to Arm(s): Conventional treatment
D: Arm Label: Free combination; Type: ACTIVE_COMPARATOR; Interventions: Drug: perindopril, indapamide , amlodipine | Arm Label: Tripliam; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tripliam (perindopril, indapamide, amlodipine) | Intervention Type: DRUG; Name: perindopril, indapamide , amlodipine; Assigned to Arm(s): Free combination | Intervention Type: DRUG; Name: Tripliam (perindopril, indapamide, amlodipine); Assigned to Arm(s): Tripliam

Answer: D